Literature DB >> 7789717

The in vivo and in vitro protective properties of taurine.

J A Timbrell1, V Seabra, C J Waterfield.   

Abstract

1. Taurine is a ubiquitous, free amino acid found in mammalian systems. 2. The biological functions of taurine are unclear. 3. Various in vivo data suggest that taurine has a variety of protective functions and deficiency leads to pathological changes. 4. Depletion in rats of taurine increases susceptibility to liver damage from carbon tetrachloride. 5. Susceptibility to a variety of hepatotoxicants correlates with the estimated hepatic taurine level. 6. In vitro data suggest that taurine can protect cells against toxic damage. 7. Taurine protects isolated hepatocytes against carbon tetrachloride, hydrazine and 1,4-naphthoquinone but not against allyl alcohol, alpha-naphthylisothiocyanate (ANIT) or diaminodiphenyl methane (DAPM) cytotoxicity. 8. The mechanisms of protection are unclear but may include modulation of calcium levels, osmoregulation and membrane stabilization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789717     DOI: 10.1016/0306-3623(94)00203-y

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  41 in total

1.  Role of the nitric oxide pathway in ischemia-reperfusion injury in isolated perfused guinea pig lungs.

Authors:  Aykut Altunkaya; Eser Oz; M Cumhur Sivrikoz; Velit Halit; Nuran Yener; Deniz Erdoĝan; Candan Ozoĝul
Journal:  Mol Cell Biochem       Date:  2006-09-14       Impact factor: 3.396

2.  The biosynthesis of taurine fromN-acetyl-L-cysteine and other precursorsin vivo and in rat hepatocytes.

Authors:  C J Waterfield; J A Timbrell
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

3.  Hepatoprotective effects of the n-butanol extract from Perralderia coronopifolia Coss. against PCP-induced toxicity in Wistar albino rats.

Authors:  Khadidja Bekhouche; Tevfik Ozen; Sara Boussaha; Ibrahim Demirtas; Mounir Kout; Kemal Yildirim; Djamila Zama; Fadila Benayache; Samir Benayache
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-28       Impact factor: 4.223

4.  Potassium-stimulated taurine release and nitric oxide synthase activity during quinolinic acid lesion of the rat striatum.

Authors:  R Böckelmann; M Reiser; G Wolf
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

5.  Conversion of taurine into N-chlorotaurine (taurine chloramine) and sulphoacetaldehyde in response to oxidative stress.

Authors:  C Cunningham; K F Tipton; H B Dixon
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 6.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

Review 7.  European Cardiac Arrhythmia Society Statement on the cardiovascular events associated with the use or abuse of energy drinks.

Authors:  Samuel Lévy; Luca Santini; Alessandro Capucci; Ali Oto; Maurizio Santomauro; Carla Riganti; Antonio Raviele; Riccardo Cappato
Journal:  J Interv Card Electrophysiol       Date:  2019-09-03       Impact factor: 1.900

8.  Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD).

Authors:  S G Maher; C E M Condron; D J Bouchier-Hayes; D M Toomey
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

9.  Metabolic assessment of a migraine model using relaxation-enhanced 1 H spectroscopy at ultrahigh field.

Authors:  Nastaren Abad; Jens T Rosenberg; Tangi Roussel; Dillon C Grice; Michael G Harrington; Samuel C Grant
Journal:  Magn Reson Med       Date:  2017-09-17       Impact factor: 4.668

10.  Combined administration of taurine and monoisoamyl DMSA protects arsenic induced oxidative injury in rats.

Authors:  Swaran J S Flora; Swapnila Chouhan; Gurusamy M Kannan; Megha Mittal; Harimohan Swarnkar
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.